Caveolin-1, caveolin-3 and VEGF expression in the masticatory muscles of mdx mice

Folia Histochemica et Cytobiologica

Volumn 49, Issue 2, 2011, Pages 291-298

  Kunert Keil, Christiane ^a   Gredes, Tomasz ^a   Lucke, Silke ^a   Morgenstern, Sven ^a   Mielczarek, Agnieszka ^b   Sporniak Tutak, Katarzyna ^c   Gedrange, Tomasz ^a   Spassov, Alexander ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Histopathology; Masticatory muscles; Mdx mice; Muscular dystrophy

Indexed keywords

CAVEOLIN 1; CAVEOLIN 3; VASCULOTROPIN; CAV1 PROTEIN, MOUSE; CAV3 PROTEIN, MOUSE; MESSENGER RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; MASTICATORY MUSCLE; MOUSE; MUSCLE REGENERATION; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKINNED MUSCLE FIBER; UPREGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT;

MURINAE; MUS;

ANIMALS; CAVEOLIN 1; CAVEOLIN 3; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MASTICATORY MUSCLES; MICE; MICE, INBRED MDX; PROTEIN TRANSPORT; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80055097168     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0041     Document Type: Article

References (46)

1. Couet J, Belanger MM, Roussel E, Drolet MC. Cell biology of caveolae and caveolin. Adv Drug Deliv Rev. 2001; 49:223-235.
2. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev. 2002;54:431-467.
3. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae- associated proteins. J Biol Chem. 1997;272:6525-6533.
4. Griffoni C, Spisni E, Santi S et al. Knockdown of caveolin- 1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem Biophys Res Commun. 2000; 276:756-761.
5. Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol. 2003;23:1161-1168.
6. Woodman SE, Ashton AW, Schubert W et al. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am J Pathol. 2003;162:2059-2068.
7. Nishiyama K, Trapp BD, Ikezu T et al. Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease. J Neurosci. 1999;19:6538-6548.
8. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 1998;273:5419-5422.
9. Schwab W, Galbiati F, Volonte D et al. Characterisation of caveolins from cartilage: expression of caveolin-1, -2 and -3 in chondrocytes and in alginate cell culture of the rat tibia. Histochem Cell Biol. 1999;112:41-49.
10. Parton RG, Way M, Zorzi N, Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol. 1997;136:137-154.
11. Song KS, Scherer PE, Tang Z et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996;271:15160-15165.
12. Chidlow JH Jr, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res. 2010;86:219-225.
13. Minetti C, Sotgia F, Bruno C et al. Mutations in the caveolin- 3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998;18:365-368.
14. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 2004; 62:538-543.
15. Galbiati F, Volonte D, Chu JB et al. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne- like muscular dystrophy phenotype. Proc Natl Acad Sci USA. 2000;97:9689-9694.
16. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919-928.
17. Campbell KP. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell. 1995;80:675-679.
18. Emery AEH, Emery MHL. Refining the clinical picture. In: Emery AEH EM (eds.). The history of a genetic disease: Duchenne muscular dystrophy or Meryons's disease. London: The Royal Society of Medicine Press Limited 1995;89-99.
19. Bonilla E, Fischbeck K, Schotland DL. Freeze-fracture studies of muscle caveolae in human muscular dystrophy. Am J Pathol. 1981;104:167-173.
20. Ito H, Yoshimura T, Tsujihata M, Nagataki S. Distribution of intramembranous particle size in the muscle plasma membrane of the mdx mouse. J Neurol Sci. 1997;148:147-151.
21. Repetto S, Bado M, Broda P et al. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun. 1999;261:547-550.
22. Vaghy PL, Fang J, Wu W, Vaghy LP. Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett. 1998;431:125-127.
23. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.
24. Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovasc Res. 2010;87:262-271.
25. Zhang ZB, Cai L, Zheng SG, Xiong Y, Dong JH. Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with Vascular Endothelial Growth Factor, microvessel density and unpaired artery. Pathol Oncol Res. 2009;15(3):495-502.
26. Labrecque L, Royal I, Surprenant DS et al. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin- 1 and plasma membrane cholesterol. Mol Biol Cell. 2003;14:334-347.
27. Spassov A, Gredes T, Gedrange T et al. Histological changes in masticatory muscles of mdx mice. Arch Oral Biol. 2010;55:318-324.
28. Kruger J, Kunert-Keil C, Bisping F, Brinkmeier H. Transient receptor potential cation channels in normal and dystrophic mdx muscle. Neuromuscul Disord. 2008;18:501-513.
29. Kunert-Keil C, Bisping F, Kruger J, Brinkmeier H. Tissue- -specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics. 2006;7:159.
30. Gredes T, Kunert-Keil C, Dominiak M et al. The influence of biocomposites containing genetically modified flax fibers on gene expression in rat skeletal muscle. Biomed Tech (Berl). 2010;55(6):331-334.
31. Gredes T, Spassov A, Mai R et al. Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants. J Physiol Pharmacol. 2009;60(Suppl 3): 77-81.
32. Gedrange T, Walter B, Tetzlaff I et al. Regional alterations in fiber type distribution, capillary density, and blood flow after lower jaw sagittal advancement in pig masticatory muscles. J Dent Res. 2003;82:570-574.
33. Shibuya S, Wakayama Y, Inoue M, Oniki H, Kominami E. Changes in the distribution and density of caveolin 3 molecules at the plasma membrane of mdx mouse skeletal muscles: a fracture-label electron microscopic study. Neurosci Lett. 2002;325:171-174.
34. Matsumoto H, Sasazaki S, Fujiwara A et al. Accumulation of caveolin-3 protein is limited in damaged muscle in chicken muscular dystrophy. Comp Biochem Physiol A Mol Integr Physiol. 2010;157:68-72.
35. Gervasio OL, Whitehead NP, Yeung EW, Phillips WD, Allen DG. TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy. J Cell Sci. 2008;121:2246-2255.
36. Allen DG, Gervasio OL, Yeung EW, Whitehead NP. Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol. 2010;88:83-91.
37. Schubert W, Sotgia F, Cohen AW et al. Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. Am J Pathol. 2007;170:316-333.
38. Barresi V, Grosso M, Barresi G. Immunohistochemical evidence of caveolin-1 expression in the human fetal and neonatal striated muscle and absence in the adult's. Appl Immunohistochem Mol Morphol. 2008;16:267-273.
39. Muller J, Vayssiere N, Royuela M et al. Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice. J Muscle Res Cell Motil. 2001;22:133-139.
40. Stedman HH, Sweeney HL, Shrager JB et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 1991;352:536-539.
41. El-Yazbi AF, Cho WJ, Cena J, Schulz R, Daniel EE. Smooth muscle NOS, colocalized with caveolin-1, modulates contraction in mouse small intestine. J Cell Mol Med. 2008;12:1404-1415.
42. Gomez-Ruiz A, Milagro FI, Campion J, Martinez JA, de Miguel C. Caveolin expression and activation in retroperitoneal and subcutaneous adipocytes: influence of a high-fat diet. J Cell Physiol. 2010;225:206-213.
43. Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 1996;7:259-270.
44. Saito T, Yamamoto Y, Matsumura T, Fujimura H, Shinno S. Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy. Brain Dev. 2009;31:612-617.
45. Messina S, Mazzeo A, Bitto A et al. VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. Faseb J. 2007;21:3737-3746.
46. Sonveaux P, Martinive P, DeWever J et al. Caveolin-1 expression is critical for vascular endothelial growth factorinduced ischemic hindlimb collateralization and nitric oxide- mediated angiogenesis. Circ Res. 2004;95:154-161.